Back
Akero Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer4.jpg)
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
AKRO
Akero Therapeutics
Last Price:
$49.93
Seasonality Move:
-13.61%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer8.jpg)
Recent Tech Boom Could Send "EarnPhone" Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
Akero Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.02 | Sell |
20-day SMA: | 42.05 | Buy |
50-day SMA: | 34.2 | Buy |
200-day SMA: | 27.85 | Buy |
8-day EMA: | 51.73 | Sell |
20-day EMA: | 45.31 | Buy |
50-day EMA: | 37.61 | Buy |
200-day EMA: | 30.47 | Buy |
Akero Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.76 | Buy |
Relative Strength Index (14 RSI): | 64.15 | Buy |
Chaikin Money Flow: | -84584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.24 - 53.26) | Buy |
Bollinger Bands (100): | (23.77 - 40.49) | Buy |
Akero Therapeutics Technical Analysis
Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Akero Therapeutics Stock
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 49.95 while AKRO 8-day simple moving average is 54.02, which is a Sell signal.
-
The stock price of AKRO is 49.95 while Akero Therapeutics 20-day SMA is 42.05, which makes it a Buy.
-
Akero Therapeutics 50-day simple moving average is 34.20 while AKRO share price is 49.95, making it a Buy technically.
-
AKRO stock price is 49.95 and Akero Therapeutics 200-day simple moving average is 27.85, creating a Buy signal.
AKRO Technical Analysis vs Fundamental Analysis
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy or a Sell?
-
Akero Therapeutics stock is rated a BuyThe current Akero Therapeutics [AKRO] share price is $49.95. The Score for AKRO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Akero Therapeutics Stock Info
Market Cap:
3.5B
Price in USD:
49.95
Share Volume:
1.4M
Akero Therapeutics 52-Week Range
52-Week High:
58.40
52-Week Low:
17.86
Buy
69
Akero Therapeutics (AKRO)
is a Buy
Akero Therapeutics Share Price Forecast
-
What is the Akero Therapeutics stock price today?The Akero Therapeutics stock price is 49.95 USD today.
-
Will AKRO stock go up or go down?Akero Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akero Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akero Therapeutics is not overvalued.
Is Akero Therapeutics Stock a Buy?
-
Akero Therapeutics share price is 49.95 while AKRO 8-day exponential moving average is 51.73, which is a Sell signal.
-
The stock price of AKRO is 49.95 while Akero Therapeutics 20-day EMA is 45.31, which makes it a Buy.
-
Akero Therapeutics 50-day exponential moving average is 37.61 while AKRO share price is 49.95, making it a Buy technically.
-
AKRO stock price is 49.95 and Akero Therapeutics 200-day simple moving average is 30.47, creating a Buy signal.
Fundamental Analysis of Akero Therapeutics
Is Akero Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Akero Therapeutics
Should I short Akero Therapeutics stock?
-
AKRO Moving Average Covergence Divergence (MACD) indicator is 6.76, suggesting Akero Therapeutics is a Buy
-
Akero Therapeutics Relative Strength Index (RSI) is 64.15, which suggest Akero Therapeutics is overbought
-
The Bollinger Bands (25) for Akero Therapeutics is (24.24 - 53.26), which suggest Akero Therapeutics is a Buy
-
The Bollinger Bands (100) for Akero Therapeutics is (23.77 - 40.49), which suggest Akero Therapeutics is a Buy
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.